Back to Market Feed

Product Information

PIFELTRO 100 MG TABLET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $60.7003 per EA under NDC 00006306901. Its NADAC has been published 357 times since Oct 23, 2019.

FDA first approved this application on Aug 30, 2018.

PIFELTRO 100 MG TABLET

doravirine
$60.7003per EA

Strength

100 mg/1

NDC

00006306901

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DORAVIRINE

Approval Type

New Drug (NDA)

FDA Application

NDA210806

FDA Approved

8/30/2018

On Market Since

7/20/2018

Pharmacological Classes

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors

Price Statistics

The NADAC for PIFELTRO 100 MG TABLET has been published 357 times since Oct 23, 2019, and over the history we have for it it has risen 35.9%. The table below summarizes its recorded NADAC range and movement.

Current price$60.7003 per EA
All-time high$60.9498 (May 13, 2026)
All-time low$44.3183 (Nov 20, 2019)
52-week high$60.9498
52-week low$59.3904
Median price$54.3347
Average price$53.4641
Largest weekly change+5.0% (Jan 15, 2020)
Weeks tracked357
Tracking sinceOct 23, 2019

Price History

1W

-0.1%

1M

-0.1%

3M

-0.1%

6M

-0.4%

1Y

+2.2%

3Y

+11.7%

5Y

+23.1%

All

+35.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the doravirine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

INTELENCE 100 MG TABLET
Brand
59676057001•Janssen Products LP
$10.9213
per EA
INTELENCE 200 MG TABLET
Brand
59676057101•Janssen Products LP
$24.3032
per EA
EDURANT 25 MG TABLET
Brand
59676027801•Janssen Products LP
$48.0606
per EA
DELSTRIGO 100-300-300 MG TAB
Brand
00006500701•Merck Sharp & Dohme LLC
$92.8925
per EA
JULUCA 50-25 MG TABLET
Brand
49702024213•ViiV Healthcare Company
$121.8817
per EA
ODEFSEY TABLET
Brand
61958210101•Gilead Sciences, Inc.
$130.2913
per EA
COMPLERA TABLET
Brand
61958110101•Gilead Sciences, Inc.
$130.3142
per EA

Frequently asked questions

What is the NADAC price of PIFELTRO 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIFELTRO 100 MG TABLET, manufactured by Merck Sharp & Dohme LLC, is $60.7003 per EA (NDC 00006306901), effective Aug 19, 2026.

How has the price of PIFELTRO 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIFELTRO 100 MG TABLET has risen 35.9%. It has been tracked across 357 weekly CMS publications since Oct 23, 2019.

What are the highest and lowest recorded NADAC prices for PIFELTRO 100 MG TABLET?

Since Oct 23, 2019, the NADAC for PIFELTRO 100 MG TABLET has ranged from a low of $44.3183 (Nov 20, 2019) to a high of $60.9498 (May 13, 2026), with a median of $54.3347 per EA.

Are there cheaper alternatives to PIFELTRO 100 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PIFELTRO 100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PIFELTRO 100 MG TABLET?

PIFELTRO 100 MG TABLET (NDC 00006306901) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.